Abbott Labs Stock Offers Favorable Entry Point Hosted by Laycee KluinOctober 26, 2023 ShareLink copied to clipboard. Play video for Abbott Labs Stock Offers Favorable Entry PointDetailsGuestsAbbott Laboratories' share price has trended lower for nearly two years, but that trend is over. The impact of the pandemic on sales and the post-pandemic letdown were cause enough for the market to sell, but not now; the market is oversold and overextended with normalization at hand. Normalization, a buzzword that can be applied to most industries today, means steadying sales of supplies offset by core business growth and, more importantly, a return to growth for this Dividend King in 2024.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioABTAbbott Laboratories4.8634 of 5 stars$131.00+1.0%1.80%17.12 Add This Stock to My Watchlist Thomas Hughes, GuestMarketBeat Contributor, MarketBeatThomas got his start with the markets while working as a Chef. In 2005 a chance invitation to attend the seminar “How To Buy And Sell Your Own Stocks” altered his worldview. Soon trading and stocks consumed his every waking moment to the point of excluding all else. Thomas now enjoys a much different lifestyle engaged in his true passion, uncovering great investments.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored7 Beaten-Down Stocks Ready to Mount a Comeback in 2025 It's a story that investors have seen play out many times. A stock that underperforms the market in one year...MarketBeatThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredThe 10 Best Lithium Stocks to Buy for a Post Gasoline WorldElectric vehicles currently make up about 5% of new car sales in the United States. While they have received a...MarketBeatTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHow to Invest In Growth StocksThe stock market has been growing since the New York Stock Exchange opened its doors in 1817. Sometimes, a sto...MarketBeat Listen to MarketBeat Other Platforms Recent Videos Featured Articles and OffersGold Rally Continues: These 3 Mining Stocks Are Likely to BenefitApril 16, 2025View Gold Rally Continues: These 3 Mining Stocks Are Likely to BenefitTrump purposefully forcing markets to crash…From Porter & Company(Ad)View Trump purposefully forcing markets to crash…Why NVIDIA Stock Could Soar Despite Wall Street DowngradesApril 14, 2025View Why NVIDIA Stock Could Soar Despite Wall Street Downgrades3 Stocks Upping Dividends & 1 With A 10% Special Dividend YieldApril 16, 2025View 3 Stocks Upping Dividends & 1 With A 10% Special Dividend YieldTesla Stock Eyes Breakout With Earnings on DeckApril 16, 2025View Tesla Stock Eyes Breakout With Earnings on DeckURGENT: This Altcoin Opportunity Won’t Wait – Act NowFrom Crypto Swap Profits(Ad)View URGENT: This Altcoin Opportunity Won’t Wait – Act Now Search Headlines Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hosted by Laycee KluinOctober 26, 2023 ShareLink copied to clipboard. Play video for Abbott Labs Stock Offers Favorable Entry PointDetailsGuestsAbbott Laboratories' share price has trended lower for nearly two years, but that trend is over. The impact of the pandemic on sales and the post-pandemic letdown were cause enough for the market to sell, but not now; the market is oversold and overextended with normalization at hand. Normalization, a buzzword that can be applied to most industries today, means steadying sales of supplies offset by core business growth and, more importantly, a return to growth for this Dividend King in 2024.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioABTAbbott Laboratories4.8634 of 5 stars$131.00+1.0%1.80%17.12 Add This Stock to My Watchlist Thomas Hughes, GuestMarketBeat Contributor, MarketBeatThomas got his start with the markets while working as a Chef. In 2005 a chance invitation to attend the seminar “How To Buy And Sell Your Own Stocks” altered his worldview. Soon trading and stocks consumed his every waking moment to the point of excluding all else. Thomas now enjoys a much different lifestyle engaged in his true passion, uncovering great investments.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored7 Beaten-Down Stocks Ready to Mount a Comeback in 2025 It's a story that investors have seen play out many times. A stock that underperforms the market in one year...MarketBeatThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredThe 10 Best Lithium Stocks to Buy for a Post Gasoline WorldElectric vehicles currently make up about 5% of new car sales in the United States. While they have received a...MarketBeatTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHow to Invest In Growth StocksThe stock market has been growing since the New York Stock Exchange opened its doors in 1817. Sometimes, a sto...MarketBeat
